NCT00962481View on ClinicalTrials.gov

Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Bimosiamose

DRUG

Placebo

Trial Locations (1)

Unknown

Pneumologisches Forschungsinstitut GmbH am Krankenhaus Großhansdorf, Großhansdorf

All Listed Sponsors
lead

Revotar Biopharmaceuticals AG

INDUSTRY

NCT00962481 - Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia | Biotech Hunter | Biotech Hunter